文献速递慢病防控与筛查卫生政策与健康促进

身高与死亡率、心血管疾病和癌症关联在低、中、高收入国家间的差异

Variations in the association of height with mortality, cardiovascular disease and cancer in low-, middle- and high-income countries.
PubMed 文献 · Int J Epidemiol · 2022-01-01

前瞻性城乡流行病学研究纳入21个国家154610名35-70岁参与者,中位随访10.1年。调整后身高每增加10cm,全因死亡HR 0.93、主要心血管事件HR 0.97、癌症HR 1.23;身高与三项结局的交互P值均<0.001,低、中、高收入国家关联不同。

要点

  • 身高每增10cm全因死亡风险HR 0.93,主要心血管事件HR 0.97,癌症HR 1.23。
  • 低收入国家身高与全因死亡(HR 0.88)和主要心血管事件(HR 0.87)呈负相关。
  • 中高收入国家身高与全因死亡及主要心血管事件无关联,癌症HR分别为1.12和1.20。

核心结论

  • 与中高收入国家不同,低收入国家中身高较高与全因死亡和主要心血管事件呈强负相关。
  • 中高收入国家儿童期体格发育改善及人群心血管治疗进步可能促成这一差距。
  • 作者假设从生命历程角度看,低收入国家优化母婴健康可能在人群层面改善过早死亡和心血管事件发生率。

研究设计与样本

  • 前瞻性城乡流行病学研究为大型纵向人群研究,在21个不同收入和社会文化背景的国家开展。
  • 纳入至少一名家庭成员年龄35-70岁的家庭,共154610名身高和生命状态已知的参与者,自2003年1月起入组。
  • 身高以标准化方式测量,脱鞋,精确至0.1cm;中位随访10.1年(四分位距8.3-12.0),使用截至2021年3月的随访事件数据。

主要发现

  • 随访期间11487名(7.4%)参与者死亡,9291名(6.0%)发生主要心血管事件,5873名(3.8%)新诊断癌症。
  • 调整后身高每增加10cm,全因死亡HR 0.93(95%CI 0.90-0.96),主要心血管事件HR 0.97(95%CI 0.94-1.00),癌症HR 1.23(95%CI 1.18-1.28)。
  • 身高与国家收入水平对三项结局的交互P值均<0.001,提示身高与这些结局的关联随国家收入水平变化。
  • 低收入国家身高与全因死亡(HR 0.88,95%CI 0.84-0.92)和主要心血管事件(HR 0.87,95%CI 0.82-0.93)呈负相关;中高收入国家身高与这两项结局无关联。
  • 癌症HR在低收入国家为1.14(95%CI 0.99-1.32),中等收入国家为1.12(95%CI 1.04-1.22),高收入国家为1.20(95%CI 1.14-1.26)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Final adult height is a useful proxy measure of childhood nutrition and disease burden. Tall stature has been previously associated with decreased risk of all-cause mortality, decreased risk of major cardiovascular events and an increased risk of cancer. However, these associations have primarily been derived from people of European and East Asian backgrounds, and there are sparse data from other regions of the world. METHODS: The Prospective Urban-Rural Epidemiology study is a large, longitudinal population study done in 21 countries of varying incomes and sociocultural settings. We enrolled an unbiased sample of households, which were eligible if at least one household member was aged 35-70 years. Height was measured in a standardized manner, without shoes, to the nearest 0.1 cm. During a median follow-up of 10.1 years (interquartile range 8.3-12.0), we assessed the risk of all-cause mortality, major cardiovascular events and cancer. RESULTS: A total of 154 610 participants, enrolled since January 2003, with known height and vital status, were included in this analysis. Follow-up event data until March 2021 were used; 11 487 (7.4%) participants died, whereas 9291 (6.0%) participants had a major cardiovascular event and 5873 (3.8%) participants had a new diagnosis of cancer. After adjustment, taller individuals had lower hazards of all-cause mortality [hazard ratio (HR) per 10-cm increase in height 0.93, 95% confidence interval (CI) 0.90-0.96] and major cardiovascular events (HR 0.97, 95% CI 0.94-1.00), whereas the hazard of cancer was higher in taller participants (HR 1.23, 95% CI 1.18-1.28). The interaction p-values between height and country-income level for all three outcomes were <0.001, suggesting that the association with height varied by country-income level for these outcomes. In low-income countries, height was inversely associated with all-cause mortality (HR 0.88, 95% CI 0.84-0.92) and major cardiovascular events (HR 0.87, 95% CI 0.82-0.93). There was no association of height with these outcomes in middle- and high-income countries. The respective HRs for cancer in low-, middle- and high-income countries were 1.14 (95% CI 0.99-1.32), 1.12 (95% CI 1.04-1.22) and 1.20 (95% CI 1.14-1.26). CONCLUSIONS: Unlike high- and middle-income countries, tall stature has a strong inverse association with all-cause mortality and major cardiovascular events in low-income countries. Improved childhood physical development and advances in population-wide cardiovascular treatments in high- and middle-income countries may contribute to this gap. From a life-course perspective, we hypothesize that optimizing maternal and child health in low-income countries may improve rates of premature mortality and cardiovascular events in these countries, at a population level.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Khetan AK, Leong DP, Gupta R, et al. Variations in the association of height with mortality, cardiovascular disease and cancer in low-, middle- and high-income countries. Int J Epidemiol. 2022. PMID: 34939099. doi:10.1093/ije/dyab268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。